KYDES Pharmaceuticals

Product Pipeline

KYDES products are developed from currently approved drug compounds and FDA approved excipients using our proprietary technologies. The products will be manufactured to meet or exceed Current Good Manufacturing Practices (CGMP) Guidelines set forth by the FDA and other Regulatory Agencies. The products listed in the menu above are in various stages of development.

Click on the products below for details.

KY1105: Treatment for persistent HPV infection and cervical dysplasia

This is a variation of KY004 for the treatment of persistent HPV infection and cervical dysplasia.